Cure My Disease

Don't miss your cure!

Home News Browse About
Log in / Sign up
← Back to home

Immunovant Sciences Gmbh

Clinical trials sponsored by Immunovant Sciences Gmbh, explained in plain language.

Trials to join now! 5 Not yet finished but already full! 3 Completed 2 Terminated 1
Sort by
  • New drug shows promise for bulging eyes in thyroid disease

    Disease control Completed

    This study tested a drug called batoclimab in 114 adults with active thyroid eye disease, a condition that causes eye bulging and inflammation. Participants received weekly injections of batoclimab or a placebo for 24 weeks. The main goal was to see if batoclimab could reduce eye…

    Phase: PHASE3 • Sponsor: Immunovant Sciences GmbH • Aim: Disease control

    Last updated May 17, 2026 06:20 UTC

  • New drug shows promise for Hard-to-Treat Graves' disease

    Disease control Completed

    This study tested a drug called batoclimab in 35 adults with Graves' disease whose thyroid levels remained high despite standard antithyroid medications. The goal was to see if 24 weeks of treatment could bring thyroid hormones back to normal or below normal without increasing th…

    Phase: PHASE2 • Sponsor: Immunovant Sciences GmbH • Aim: Disease control

    Last updated May 11, 2026 20:47 UTC

Cure My Disease

Helping patients find clinical trials that match their disease.

Why was Cure my disease built?

Explore

Home News Browse About Terms of use Contact us

This is a site from Cyber and Space